ArticleFrontiers in veterinary science2026
Outbreak of porcine deltacoronavirus in pigs in central China, 2024.
Article in Frontiers in veterinary science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Porcine deltacoronavirus (PDCoV) is an emerging enteropathogenic coronavirus responsible for acute diarrhea, vomiting, and dehydration in piglets, thereby posing a substantial threat to the global swine industry. In December 2024, a severe diarrheal disease outbreak occurred on an intensive pig farm in Hubei Province, located in central China. Here, we describe the isolation and genomic characterization of a novel PDCoV strain, designated SP2403-2, obtained from the intestinal contents of an affected piglet. The virus was successfully propagated in cell culture and confirmed by immunofluorescence staining and transmission electron microscopy. The near-complete genome of SP2403-2, comprising 25,244 nucleotides, was sequenced. Comparative genomic analyses showed that SP2403-2 shares 97.0-99.2% nucleotide identity with reference PDCoV strains, with the highest similarity (99.2%) to the recently reported Chinese strain JSTZ2025. Phylogenetic analyses based on complete genome, ORF1ab, and S gene sequences demonstrated that SP2403-2 belongs to the Chinese lineage. Notably, alignment of the spike (S) protein of SP2403-2 with that of the vaccine strain CHN-HN-2014 revealed 25 amino acid substitutions. Structural mapping indicated that these mutations are predominantly located on the surface-exposed regions of critical domains within the S protein, potentially influencing antigenic epitopes and receptor-binding properties. Our findings demonstrate that SP2403-2 represents a contemporary Chinese-lineage PDCoV strain carrying substantial S protein variation relative to the vaccine strain, underscoring the imperative for ongoing surveillance of emerging PDCoV variants and re-evaluation of current vaccine efficacy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.